ENTITY
Jinlong Rare Earth
Jinlong Rare Earth
PulseAugur coverage of Jinlong Rare Earth — every cluster mentioning Jinlong Rare Earth across labs, papers, and developer communities, ranked by signal.
Total · 30d
0
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
- 2026-05-29 funding Xiamen Tungsten's subsidiary, Jinlong Rare Earth, is planning an IPO on the Beijing Stock Exchange to fund production line upgrades and expansion. source
RECENT · PAGE 1/1 · 2 TOTAL
-
Fosun Pharma subsidiary's breast cancer drug approved in China
Fosun Pharma announced that its subsidiary, Shanghai Fosun Pharmaceutical Biotechnology Co., Ltd., has received approval from China's National Medical Products Administration for its Pertuzumab Injection. This approval …
-
Xiamen Tungsten subsidiary plans Beijing Stock Exchange listing
Xiamen Tungsten's subsidiary, Jinlong Rare Earth, plans to list on the Beijing Stock Exchange. The company intends to issue up to 278 million shares, with net proceeds earmarked for upgrading its rare earth permanent ma…